Table 1 (abstarct P06). Baseline characteristics and third interim analysis data of patients with FMF

Number of patients, N

54

11

35

7

16

3

Number (%*) of patients in disease remission (physician assessment)

18   (48.6)

1         (20.0)

19          (73.1)

3          (75.0)

8        (61.5)

1        (100.0)

Patient assessment of current disease activity; 0–10, median (min; max)

3.0          (0; 10)

7.0           (0; 10)

2.5                 (0; 7)

2.0              (0; 5)

2.0               (0; 6)

0.5               (0; 1)

Patient assessment of current fatigue; 0–10, median (min; max)

5.0         (0; 10)

5.0           (0; 9)

3.5                    (0; 10)

3.0             (1; 6)

3.0               (0; 7)

0.5               (0; 1)

Number (%*) of patients without impairment of social life by the disease

19      (46.3)

3                 (37.5)

18                       (66.7)

3                 (75.0)

5               (55.6)

2                 (66.7)

CRP/SAA, median (mg/dl)

0.2/0.7

1.1/6.8

0.2/0.8

0.1/0.4

0.1/0.6

0.5/0.7